◀ Back to IL15

IL15 — TGFB3

Text-mined interactions from Literome

Bry et al., Am J Obstet Gynecol 1992 (Obstetric Labor, Premature) : Human amnion cells in monolayer culture were treated with interleukin-1 , tumor necrosis factor, or vehicle in the presence or absence of transforming growth factor-beta
Roberts et al., Mol Hum Reprod 2005 : We also showed that tumour necrosis factor-alpha ( TNF-alpha ; 10 and 25 ng/ml ) and transforming growth factor-beta ( TGF-beta; 1 and 5 ng/ml ), cytokines with inflammatory and immune regulatory functions in a cell- and dose dependent manner regulate the expression of IL-13 and IL-15 ( P < 0.05 )
Layh-Schmitt et al., Curr Opin Rheumatol 2008 (Spondylarthropathies) : In mice, transforming growth factor-beta and interleukin-6 are critical, whereas interleukin-23 is more important at later stages promoting interleukin-17 production
Marth et al., Eur J Immunol 1997 : Regulation of transforming growth factor-beta production by interleukin-12
Fulton et al., J Infect Dis 1998 : Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta , tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra